Israeli entrepreneur and founder of Novel Concepts Medical, Rachel Alkalay, has gained international recognition for her groundbreaking contributions to medical research.
Recognized as a pioneering inventor by the International Federation of Intellectual Property Lawyers (FICPI), Mr. Alcalai's innovative work has earned him prestigious awards and honors such as the Global Health & Pharma Award and the Biotechnology Award. I am.
Novel Concepts Medical, founded by Dr. Alkalay in 2020, is an innovation company using natural compounds for various medical conditions such as Covid-19, Alzheimer's disease, cancer, obesity, diabetes, and anemia. The company focuses on research and development of innovative solutions.
Inspired by his father's old notes, Dr. Alkalay embarked on scientific research into the potential medicinal properties of plants in response to the COVID-19 pandemic. Her experience gained from her work in Israel, New York, and London made her realize the untapped potential of plant-based therapies in modern medicine.
“About a third of the world's medicines are made from plants,” explains Dr. Alkalay. “Plants are an attractive avenue for researchers seeking new drugs and treatments.”
In 2020, Dr. Alkalay began developing antiviral drugs for the novel coronavirus disease (Covid-19). Through rigorous testing in multiple laboratories, her invention demonstrated promising results in effectively blocking coronavirus entry into human cells. Dr. Alkalay's research, in collaboration with prominent laboratories in Israel and the Center for Infectious Diseases at McMaster University in Canada, has helped advance her understanding of viral diseases.
Dr. Alkalay's research extends beyond COVID-19 to Alzheimer's disease after observing COVID-19 patients who experienced short-term memory loss. Her team has developed a new formulation that shows promise in the prevention and treatment of Alzheimer's disease, bringing hope to millions of people suffering from cognitive decline.
“This scientific advance holds promise for people suffering from memory loss, dementia, and Alzheimer's disease,” Dr. Alkalay says. “Because our formula is derived from safe and legal plants, we expect it to be introduced as a dietary supplement in the near future.”
Dr. Alkalay's company continues to conduct pioneering research, exploring treatments for diseases related to metabolic syndrome, such as cancer and diabetes. Successful trials in volunteers demonstrated significant reductions in blood sugar levels and body weight, providing a new means of managing these conditions.
Rachel Alkare's dedication to advancing medical research and improving medical outcomes puts her at the forefront of innovation, bringing hope to patients around the world.
